According to multiple recent market analyses, the global API market is experiencing steady growth. One comprehensive forecast projects the global active pharmaceutical ingredient market to expand from ...

ST. LOUIS--(BUSINESS WIRE)--The drug API Innovation Center today announced it has reached a milestone in the development of technology essential to accelerating the U.S. production of lomustine, a ...

Acquisition adds API security testing to Radware’s comprehensive API security portfolio, extending protection to all stages of the API lifecycleMAHWAH, N.J., Jan. 26, 2026 (GLOBE NEWSWIRE) -- Radware® ...

With plans to expand its domestic active pharmaceutical ingredient (API) production in the U.S., AbbVie will invest $195 million to build a new manufacturing facility in North Chicago, Illinois. This ...

“Our customers, in partnership with federal and state agencies, are reshoring drug manufacturing in the U.S., the world’s largest pharmaceutical market. Local API production is vital for supply chain ...

Wuxi STA, a subsidiary of WuXi AppTec, continued its manufacturing expansion march with the opening of another high-potency active pharmaceutical ingredient (HPAPI) production facility in China. The ...

Cequence Security, the provider of unified API protection, is unveiling the latest testing capabilities—API Security Testing—for its unified API protection platform. Focused on pre-production ...

Radware’s API Security Service delivers unified, end-to-end runtime protection across the API lifecycle—combining continuous ...

The project, approved in 2008, was meant to anchor the industry’s next phase of growth. Nearly two decades later, the site remains largely idle ...